BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 31221952)

  • 1. Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Devillier R; Galimard JE; Blaise D; Raiola AM; Bramanti S; Grillo G; Pastano R; de Latour RP; Busca A; López-Corral L; Rodríguez AB; Schmid C; Forcade E; Vydra J; Solano C; Bug G; Neubauer A; Charbonnier A; Brissot E; Nagler A; Ciceri F; Mohty M
    Am J Hematol; 2024 Jul; 99(7):1250-1256. PubMed ID: 38778766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood stem cell transplantation from haploidentical related donor could achieve satisfactory clinical outcomes for intermediate- or high-risk adult acute myeloid leukemia patients.
    Cao LQ; Huo WX; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Huang XJ; Mo XD
    Bone Marrow Transplant; 2024 Feb; 59(2):203-210. PubMed ID: 37968447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T Cell-Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation for Treatment of T-Lymphoblastic Lymphoma.
    Guan L; Li X; Wei H; Gu Z; Zhao S; Zhu C; Yang N; Wang F; Luo L; Gao Z; Huang W; Li H; Wang Q; Liu D; Wu X; Gao C
    Ann Transplant; 2018 Jun; 23():427-433. PubMed ID: 29930241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplantation predictors of survival in nonremission acute myeloid leukemia treated with haploidentical transplantation using steroid-based GVHD prophylaxis.
    Teramoto M; Tamaki H; Kaida K; Samori M; Takahashi-Hirata S; Utsunomiya N; Katayama A; Fukunaga K; Inoue T; Yoshihara K; Ikegame K; Okada M; Yoshihara S
    Ann Hematol; 2024 Apr; 103(4):1363-1372. PubMed ID: 38393656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and Prognostic Factors of Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia].
    Shi YP; Cai B; Yu CL; Qiao JH; Chen XR; Lei YY; Wang Y; Yao B; Li BX; Liu TQ; Ai HS; Guo M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1852-1859. PubMed ID: 38071072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study.
    Baena JC; Rosales MC; Estacio M; Hidalgo A; Arrieta E; Jaramillo FJ; Manzi E; Parra-Lara LG; Rosales JD
    J Hematol; 2023 Dec; 12(6):255-267. PubMed ID: 38188474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease.
    Saraf SL; Oh AL; Patel PR; Sweiss K; Koshy M; Campbell-Lee S; Gowhari M; Jain S; Peace D; Quigley JG; Khan I; Molokie RE; Mahmud N; Gordeuk VR; Rondelli D
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1759-1765. PubMed ID: 29656137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of haploidentical haematopoietic stem cell transplantation for adolescent and young adults with acute myeloid leukaemia.
    Huo WX; Wen Q; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Huang XJ; Mo XD
    Br J Haematol; 2023 Aug; 202(4):856-865. PubMed ID: 37365147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy.
    Avenoso D; Serpenti F; Slonim LB; Bouziana S; Dazzi F; Hannah G; Kenyon M; Mehra V; Kulasekararaj A; Krishamurthy P; Shah MN; Lionel S; Pagliuca A; Potter V
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024002. PubMed ID: 38223487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparisons of occurrence and curative effect of interstitial pneumonia after the related HLA-haploidentical and HLA-matched sibling peripheral blood hematopoietic stem cell transplantation].
    Wang XY; Jiang M; Qu JH; Duan XL; Yuan HL; Wang L; Xu JL; Ding LL; Nadia Abdul C; Li L; Eed A; Guo XH; Wen BZ
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):458-63. PubMed ID: 27431067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmanipulated haploidentical hematopoietic stem cell transplantation for mixed phenotype acute leukemia: a single center study.
    Huang J; Feng B; Cheng Y; Xu L; Zhang X; Huang X; Wang Y
    Bone Marrow Transplant; 2024 Jan; 59(1):147-149. PubMed ID: 37903993
    [No Abstract]   [Full Text] [Related]  

  • 12. G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Acute Leukemia Patients in the First Complete Remission: A Registered Study.
    Ma YR; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X; Mo X
    Front Oncol; 2021; 11():631625. PubMed ID: 33791217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical, Unmanipulated Granulocyte Colony-Stimulating Factor (G-CSF)-Primed Peripheral Blood Stem Cell Transplants for Acute Myeloid Leukemia (AML) in Remission: A Single Center Experience.
    Luo L; Fang S; Zhao S; Li F; Zhou Y; Guan L; Yang N; Gu Z; Lin T; Wang F; Zhu C; Huang W; Liu D; Gao C
    Ann Transplant; 2019 Jun; 24():367-373. PubMed ID: 31221952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest China.
    Gao L; Wen Q; Chen X; Liu Y; Zhang C; Gao L; Kong P; Zhang Y; Li Y; Liu J; Wang Q; Su Y; Wang C; Wang S; Zeng Y; Sun A; Du X; Zeng D; Liu H; Peng X; Zhang X
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):1932-9. PubMed ID: 25109850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update.
    Huang WR; Li HH; Gao CJ; Bo J; Li F; Dou LP; Wang LL; Jing Y; Wang L; Liu DH; Yu L
    Bone Marrow Transplant; 2016 Nov; 51(11):1464-1469. PubMed ID: 27322853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical transplants with a G-CSF/ATG-based protocol: Experience from China.
    Xu ZL; Huang XJ
    Blood Rev; 2023 Nov; 62():101035. PubMed ID: 36404244
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.